Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3368038rdf:typepubmed:Citationlld:pubmed
pubmed-article:3368038lifeskim:mentionsumls-concept:C0021494lld:lifeskim
pubmed-article:3368038lifeskim:mentionsumls-concept:C2349001lld:lifeskim
pubmed-article:3368038lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:3368038lifeskim:mentionsumls-concept:C0681850lld:lifeskim
pubmed-article:3368038lifeskim:mentionsumls-concept:C1706203lld:lifeskim
pubmed-article:3368038lifeskim:mentionsumls-concept:C2697811lld:lifeskim
pubmed-article:3368038lifeskim:mentionsumls-concept:C0036982lld:lifeskim
pubmed-article:3368038lifeskim:mentionsumls-concept:C0037167lld:lifeskim
pubmed-article:3368038lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:3368038lifeskim:mentionsumls-concept:C1550501lld:lifeskim
pubmed-article:3368038lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:3368038pubmed:issue2lld:pubmed
pubmed-article:3368038pubmed:dateCreated1988-6-21lld:pubmed
pubmed-article:3368038pubmed:abstractTextIn rats bled to invariably fatal haemorrhagic shock (mean arterial pressure = 18-24 mmHg), the prompt and sustained improvement of cardiovascular function, obtained with the i.v. injection of cholecystokinin octapeptide (CCK-8, 20 g/kg) is associated with a massive increase in the volume of residual circulating blood (0.69 +/- 0.12 ml/100 g b.w. in saline-treated rats; 1.61 +/- 0.09 ml/100 g b.w. in CCK-8-treated rats). The number of red cells/mm3 and the % Hb content is the same in CCK-8-treated and in control rats. So, in a condition of severe haemorrhage, otherwise incompatible with survival, the i.v. injection of CCK-8 not only induces an impressive increase in arterial pressure and in circulating blood volume, but also greatly improves tissue oxygenation.lld:pubmed
pubmed-article:3368038pubmed:languageenglld:pubmed
pubmed-article:3368038pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3368038pubmed:citationSubsetIMlld:pubmed
pubmed-article:3368038pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3368038pubmed:statusMEDLINElld:pubmed
pubmed-article:3368038pubmed:issn0143-4179lld:pubmed
pubmed-article:3368038pubmed:authorpubmed-author:LeuFFlld:pubmed
pubmed-article:3368038pubmed:authorpubmed-author:BertoliniAAlld:pubmed
pubmed-article:3368038pubmed:authorpubmed-author:BazzaniCClld:pubmed
pubmed-article:3368038pubmed:authorpubmed-author:GuariniSSlld:pubmed
pubmed-article:3368038pubmed:issnTypePrintlld:pubmed
pubmed-article:3368038pubmed:volume11lld:pubmed
pubmed-article:3368038pubmed:ownerNLMlld:pubmed
pubmed-article:3368038pubmed:authorsCompleteYlld:pubmed
pubmed-article:3368038pubmed:pagination69-72lld:pubmed
pubmed-article:3368038pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:3368038pubmed:meshHeadingpubmed-meshheading:3368038-...lld:pubmed
pubmed-article:3368038pubmed:meshHeadingpubmed-meshheading:3368038-...lld:pubmed
pubmed-article:3368038pubmed:meshHeadingpubmed-meshheading:3368038-...lld:pubmed
pubmed-article:3368038pubmed:meshHeadingpubmed-meshheading:3368038-...lld:pubmed
pubmed-article:3368038pubmed:meshHeadingpubmed-meshheading:3368038-...lld:pubmed
pubmed-article:3368038pubmed:meshHeadingpubmed-meshheading:3368038-...lld:pubmed
pubmed-article:3368038pubmed:meshHeadingpubmed-meshheading:3368038-...lld:pubmed
pubmed-article:3368038pubmed:meshHeadingpubmed-meshheading:3368038-...lld:pubmed
pubmed-article:3368038pubmed:meshHeadingpubmed-meshheading:3368038-...lld:pubmed
pubmed-article:3368038pubmed:meshHeadingpubmed-meshheading:3368038-...lld:pubmed
pubmed-article:3368038pubmed:articleTitleHaematological changes induced by the intravenous injection of CCK-8 in rats subjected to haemorrhagic shock.lld:pubmed
pubmed-article:3368038pubmed:affiliationInstitute of Pharmacology, University of Modena, Italy.lld:pubmed
pubmed-article:3368038pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3368038lld:pubmed